These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 582766)

  • 21. Effect of beta-escin sodium on endothelial cells proliferation, migration and apoptosis.
    Wang XH; Xu B; Liu JT; Cui JR
    Vascul Pharmacol; 2008; 49(4-6):158-65. PubMed ID: 18718875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [On the pharmacodynamics of alpha- and beta-escin after oral application (author's transl)].
    Eisenburger R; Hofrichter G; Liehn HD; Ludwig E
    Arzneimittelforschung; 1976; 26(5):821-4. PubMed ID: 1085632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of stretch or distention on phenylephrine-induced constriction of human coronary artery bypass grafts.
    Wendling WW; Krasner LJ; Cooper SC; Chen D; Harakal C; Addonizio VP; Brister NW; Carlsson C
    J Cardiothorac Vasc Anesth; 2001 Dec; 15(6):717-22. PubMed ID: 11748519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of horse chestnut extracts on venous tone].
    Lochs H; Baumgartner H; Konzett H
    Arzneimittelforschung; 1974 Sep; 24(9):1347-50. PubMed ID: 4611437
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects of morphine, nalbuphine, and butorphanol on adrenergic function in canine saphenous veins.
    Muldoon S; Otto J; Freas W; Watson RL
    Anesth Analg; 1983 Jan; 62(1):21-8. PubMed ID: 6129820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The human saphenous vein in pharmacology: effect of a new micronized flavonoidic fraction (Daflon 500 mg) on norepinephrine induced contraction.
    Juteau N; Bakri F; Pomies JP; Foulon C; Rigaudy P; Pillion G; Lange G; Genre O; Cron JP
    Int Angiol; 1995 Sep; 14(3 Suppl 1):8-13. PubMed ID: 8919257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of contraction induced by bradykinin in the rabbit saphenous vein.
    Eguchi D; Nishimura J; Kobayashi S; Komori K; Sugimachi K; Kanaide H
    Br J Pharmacol; 1997 Feb; 120(3):371-8. PubMed ID: 9031738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Responses of human gastroepiploic arteries to vasoactive substances: comparison with responses of internal mammary arteries and saphenous veins.
    Ochiai M; Ohno M; Taguchi J; Hara K; Suma H; Isshiki T; Yamaguchi T; Kurokawa K
    J Thorac Cardiovasc Surg; 1992 Aug; 104(2):453-8. PubMed ID: 1495310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Modification of venous function after pharmacologic treatment. Plethysmographic study].
    Pedrini L; Cifiello BI
    Clin Ter; 1983 Aug; 106(4):271-7. PubMed ID: 6627896
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on toxicity and fertility of escin in the rat (author's transl)].
    von Kreybig T; Prechtel K
    Arzneimittelforschung; 1977 Jul; 27(7):1465-6. PubMed ID: 578474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Mechanism for Cellular Response to β-Escin and Its Therapeutic Implications.
    Domanski D; Zegrocka-Stendel O; Perzanowska A; Dutkiewicz M; Kowalewska M; Grabowska I; Maciejko D; Fogtman A; Dadlez M; Koziak K
    PLoS One; 2016; 11(10):e0164365. PubMed ID: 27727329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mode of action of aescin and the release of prostaglandins.
    Berti F; Omini C; Longiave D
    Prostaglandins; 1977 Aug; 14(2):241-9. PubMed ID: 897216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human greater and canine lateral saphenous veins. A morphologic and pharmacologic study.
    Goldberg MR; Joiner PD; Hyman AL; Kadowitz J
    Blood Vessels; 1975; 12(2):89-97. PubMed ID: 1139045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Kidney and metabolic function in parenteral and enteral nutrition. Experimental study by beta-eschin medication].
    Feldmeier C; Hoffmann K; Prechtel K
    Ther Ggw; 1978 Sep; 117(9):1342-62. PubMed ID: 99835
    [No Abstract]   [Full Text] [Related]  

  • 35. A possible role of lysosomal enzymes in the pathogenesis of varicosis and the reduction in their serum activity by Venostasin.
    Kreysel HW; Nissen HP; Enghofer E
    Vasa; 1983; 12(4):377-82. PubMed ID: 6659692
    [No Abstract]   [Full Text] [Related]  

  • 36. Reactivity of the human saphenous vein to various vasoactive agents.
    Annoni F; Mantegazza P; Montorsi W; Riesele LF
    Vasa; 1978; 7(4):360-9. PubMed ID: 726602
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of escin on adrenocorticotropin and corticosterone levels in rat plasma.
    Hiai S; Yokoyama H; Oura H
    Chem Pharm Bull (Tokyo); 1981 Feb; 29(2):490-4. PubMed ID: 6268314
    [No Abstract]   [Full Text] [Related]  

  • 38. The mode of action of aescin on isolated veins: relationship with PGF2 alpha.
    Longiave D; Omini C; Nicosia S; Berti F
    Pharmacol Res Commun; 1978 Feb; 10(2):145-52. PubMed ID: 652841
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of agents increasing the resistance of the vascular wall as well as of trasylol (a protease inhibitor) on experimental brain edema].
    Czernicki Z
    Neurol Neurochir Pol; 1977; 11(4):457-60. PubMed ID: 302426
    [No Abstract]   [Full Text] [Related]  

  • 40. Aescin: pharmacology, pharmacokinetics and therapeutic profile.
    Sirtori CR
    Pharmacol Res; 2001 Sep; 44(3):183-93. PubMed ID: 11529685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.